Encompass Health Corporation

EHCNYSEHealthcare● Active

$104.01

+$4.17(+4.18%)

Market Cap$10.3B

P/E Ratio—

52W High$127.99

52W Low$92.77

Avg Volume937K

Open$101.34

Beta0.59

Free Cash Flow Financials Revenue

Encompass Health Corporation (EHC) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

EHC · free cash flow · updated Jun 8, 2026

Core FCF metrics

EHC · FCF · TTM · margin & CAGR

Free cash flow was $439.2M for FY2025 (fiscal year ending 2025-12-31), up 21.9% year-over-year The FCF margin was 7.4%. Five-year CAGR stands at +8.2%.

FY2025 Free Cash Flow$439.2M▲ +21.9% YoY

Trailing 12M (TTM)$464.4Mtrailing 4 quarters sum

FCF Margin7.4%$439.2M ÷ revenue

3-Year CAGR+53.4%FY2022 → FY2025

5-Year CAGR+8.2%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

EHC · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$1.18B(736M)$439.2M▲ +21.9%7.4%

FY2024$1.00B(643M)$360.3M▲ +34.6%6.7%

FY2023$850.8M(583M)$267.7M▲ +120.0%5.6%

FY2022$705.8M(584M)$121.7M▼ 26.1%2.8%

FY2021$715.8M(551M)$164.6M▼ 44.5%4.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

EHC · P/FCF · FCF yield · FCF per share

Encompass Health Corporation (EHC) trades at a FCF yield of 4.50% and a price-to-free-cash-flow ratio of 22.5x. FCF per share stands at $4.62, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

4.50%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$4.62

TTM FCF ÷ Shares Outstanding

Price / FCF

x22.5

Share Price ÷ FCF per Share

EV / FCF (TTM)

x27.9

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

EHC · cash flow statement · operating / investing / financing

For FY2025, Encompass Health Corporation generated $1.18B in operating cash flow and spent 736M in capital expenditures, yielding $439.2M in free cash flow.

Operating Activities

+$1.18B

Cash from core business operations

2025-12-31

Investing Activities

−$762.8M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$433.0M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($1.18B) − |CapEx| (736M) = FCF ($439.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

EHC vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Encompass Health CorporationYOU

EHC

$439.2M+21.9%7.4%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Encompass Health Corporation (EHC) reported free cash flow of $439.2M for FY2025 (fiscal year ending 2025-12-31), up 21.9% year-over-year. The FCF margin was 7.4%.

Based on available data, Encompass Health Corporation has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $491.9M in FY2018. The 5-year CAGR stands at +8.2%.

Encompass Health Corporation's FCF yield is 4.50% and price-to-FCF ratio is 22.5x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

EHC free cash flow · 8 questions

Encompass Health Corporation free cash flow was $439.2M for FY2025, up 21.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $464.4M.

EHC free cash flowEHC FCFEHC FCF 2025EHC free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Encompass Health Corporation · Encompass Health Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026